Dr. Lal PathLabs' First-Ever Bonus Issue: Board Meeting Today To Announce Q2 Results & Interim Dividend

Dr. Lal PathLabs Ltd., one of India's leading diagnostic service providers and a BSE 500 listed company, has announced that its board of directors will meet on Friday, October 31, 2025, to review a packed agenda that includes the company's Q2FY26 financial results, a potential bonus issue, and the declaration of a second interim dividend for the financial year 2025-26.

Dr. Lal PathLabs Q2 Results FY26: Board Meeting Today on 31st October 2025

In its regulatory filing, the company said the meeting will consider and approve the un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. The results are expected to reflect steady operational performance amid expanding diagnostic services demand across India.

The pharma company announced, "This is to inform you that a meeting of the Board of Directors is scheduled to be held on Friday, October 31, 2025, to, inter alia, consider the declaration of the 2nd Interim Dividend, if any, on the Equity Shares of the Company for the Financial Year 2025-26 and consider the issuance of bonus shares in accordance with the applicable provisions and subject to the approval of the Shareholders of the Company."

First-Ever Bonus Issue: Dr Lal Pathlab's Bonus Shares

Dr. Lal PathLabs stated that the board will also consider a proposal to issue bonus shares in accordance with applicable regulations, subject to shareholder approval. However, the company did not disclose any details regarding the potential bonus issue ratio.

The bonus issue will be carried out in accordance with applicable provisions and will be subject to shareholder approval.

Pharma Stock Interim Dividend Announcement Expected

The board will also discuss and possibly approve the second interim dividend for FY26. Dr. Lal PathLabs has maintained a consistent record of rewarding shareholders through dividend payouts, highlighting its strong financial health and focus on shareholder returns.

For FY26, the company has already disbursed a first interim dividend of Rs 6 per share, with the ex-dividend date in August 2025.

According to Trendlyne data, Dr. Lal PathLabs has distributed 24 dividends since July 2016, including interim and final payouts. Over the past 12 months, the total dividend per share stood at Rs 24, translating to a dividend yield of around 0.76% at current market levels.

About Dr. Lal PathLabs Ltd

Established in 1949, Dr. Lal PathLabs is India's largest and most respected diagnostic service provider, known for its adherence to international standards and quality benchmarks. Over the decades, the company has built a pan-India presence with a robust network of laboratories and patient service centers across major cities and towns. The company offers one of the widest diagnostic test menus in the country, catering to a broad base of customers, including hospitals, clinics and individuals.